Clinical Trials Browser

OTHER × Interventional × HER2-Positive Solid Tumors × Clear all

NCT04280341 2023-08-25

JS001 in Combination With RC48-ADC in Treatment of HER2-Positive Advanced Malignant Solid Tumors

Phase 1 Unknown

Other solid neoplasm

HER2-Positive Solid Tumors